Citations

Mayo Clinic

Showing 10 of 108551 citations.

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
Group, Australian Ovarian Cancer Study, Study, Australian Cancer, Johnatty, Sharon E. , Lu, Yi , Beesley, Jonathan, Gao, Bo , Kalimutho, Murugan , Henderson, Michelle J. , Russell, Amanda J. , Kar, Siddhartha , Chen, Xiaoqing, Hillman, Kristine M. , Kaufmann, Susanne, Sivakumaran, Haran , O’Reilly, Martin, Wang, Chen , Korbie, Darren , Lambrechts, Diether , Despierre, Evelyn, Nieuwenhuysen, Els Van , Lambrechts, Sandrina, Vergote, Ignace , Lester, Jenny, Oršulić, Sandra , Walsh, Christine M. , Fasching, Peter A. , Beckmann, Matthias W. , Ekici, Arif B. , Hein, Alexander , Matsuo, Keitaro , Hosono, Satoyo , Pisterer, Jacobus, Hillemanns, Peter , Nakanishi, Toru , Yatabe, Yasushi , Goodman, Marc T. , Lurie, Galina, Matsuno, Rayna K., Thompson, Pamela J., Bean, Yukie T., Heitz, Florian , Harter, Philipp , Schwaab, Ira, Høgdall, Estrid , Jensen, Allan , Høgdall, Claus , Lundvall, Lene, Engelholm, Svend Aage, Brown, Bob, Flanagan, James M. , Metcalf, Michelle, Sellers, Thomas A. , Cunningham, Julie M. , Schildkraut, Joellen M. , Iversen, Ed , Weber, Rachel Palmieri , Brennan, Donal J. , Harnett, Paul R. , Haber, Michelle , Goode, Ellen L. , Lee, Jason S. , Khanna, Kum Kum , Meyer, Kerstin B. , Chenevix‐Trench, Georgia , DeFazio, Anna , Edwards, Stacey L. , MacGregor, Stuart , Brown, Robert , Lambrechts, Diether , Cunningham, Julie, Fazio, Anna de , French, Juliet D. , Group, Australian Ovarian Cancer Study, Study, Australian Cancer, Beesley, Jonathan, Chen, Xiaoqing, Karlan, Beth Y. , Pejovic, Tanja B. , Bois, Andreas du , Kjær, Susanne K. , Brown, Bob, Siddiqui, Nadeem , Fridley, Brooke L. , Berchuck, Andrew , Pharoah, Paul D.P. , Norris, Murray D , Lambrechts, Diether , Hein, Alexander , Hillemanns, Peter , Jensen, Allan , Haber, Michelle , Wang, Chen , Brown, Robert , Matsuo, Keitaro , Flanagan, James M , Heitz, Florian , Lambrechts, Diether , Ekici, Arif B , Lu, Yi , MacGregor, Stuart , Chenevix-Trench, Georgia , Høgdall, Estrid , Høgdall, Claus K , Kar, Siddhartha , Harnett, Paul R , Goodman, Marc T

Oncotarget | January 31, 2016 | Volume: 7 | Issue: 6 | Pages: 6353-6368

10.18632/oncotarget.7047 | PMID 26840454 Get It

Reducing the risk of transfusion‐transmitted cytomegalovirus infection: a systematic review and meta‐analysis
Mainou, Maria , Alahdab, Fares , Asi, Noor, Mohammed, Khaled , Murad, M. Hassan , Tobian, Aaron A.R. , Grossman, Brenda J. , Murad, M Hassan , Alahdab, Fares

Transfusion | January 30, 2016 | Volume: 56 | Issue: 6pt2 | Pages: 1569-1580

10.1111/trf.13478 | PMID 26826015 Get It

BACKGROUNDLeukoreduced (LR) or cytomegalovirus (CMV)‐seronegative cellular blood components are commonly used to reduce the risk of transfusion‐transmitted CMV infection in high‐risk patients.STUDY DESIGN AND METHODSWe performed a systematic review and meta‐analysis to evaluate the evidence for the use of LR cellular blood components with or without concurrent CMV testing of donor units in patients undergoing chemotherapy or solid organ and hematopoietic stem cell transplantation, in pregnant women, in very‐low‐birthweight infants, and in patients with primary immunodeficiency. We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus from 1980 through February 2015. Studies were included if they had a comparison group. Two independent reviewers selected and appraised studies. Meta‐analysis was performed when appropriate.RESULTSOf 457 studies screened, 11 were eligible. One study was excluded from the meta‐analysis because the comparison performed differed significantly from the others. Meta‐analysis of five studies that compared leukoreduction to transfusing CMV‐untested blood components showed no significant difference in clinical CMV infection (relative risk [RR], 0.26; 95% confidence interval [CI], 0.04‐1.57) or laboratory CMV infection (RR, 0.33; 95% CI, 0.08‐1.37). Meta‐analysis of three studies that compared leukoreduction to transfusing CMV‐seronegative cellular components showed no significant difference in laboratory CMV infection (RR, 2.18; 95% CI, 0.96‐4.98). Meta‐analysis of two studies that compared adding CMV testing to leukoreduction (vs. leukoreduction alone) showed no significant difference in clinical or laboratory CMV infection. The certainty in estimates was low for all comparisons.CONCLUSIONAt present, the scientific evidence does not favor a single strategy for reducing the risk of transfusion‐related CMV infection in high‐risk patients.
The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice
Zhang, Zubin , Tong, Jiefei , Tang, Xiaowen , Juan, Jiaxiang , Cao, Biyin, Hurren, Rose, Chen, Guodong , Taylor, Paul , Xu, Xin , Shi, Chang-Xin, Hou, Jian , Wang, Guanghui , Stewart, A. Keith, Schimmer, Aaron D. , Mao, Xinliang , Chen, Guodong, Du, Juan , Wu, Depei , Moran, Michael F.

Blood | January 30, 2016 | Volume: 127 | Issue: 13 | Pages: 1676-1686

10.1182/blood-2015-07-658203 | PMID 26825710 Get It

Key Points HERC4 is the first identified ubiquitin ligase that mediates c-Maf ubiquitination and degradation. HERC4 suppresses MM cell proliferation and delays MM tumor growth.
Minocycline-Induced Cutaneous Hyperpigmentation in an Orthopedic Patient Population
Hanada, Yuri , Berbari, Elie F. , Steckelberg, James M.

Open Forum Infectious Diseases | January 30, 2016 | Volume: 3 | Issue: 1 | Pages: No page available

10.1093/ofid/ofv107 | PMID 26835479 Get It

Abstract Background. The objectives of this study were to estimate the incidence and evaluate risk factors for development of minocycline-induced cutaneous hyperpigmentation in patients with orthopedic infections. Methods. Patients with orthopedic infections evaluated at Mayo Clinic (Rochester, MN) and treated with minocycline from 1 January 2002 to 31 December 2011 were retrospectively identified. Long-term minocycline suppression was defined as daily minocycline use for at least 3 months. A proportional hazards model was used to evaluate potential risk factors. Results. Of 291 patients receiving long-term minocycline suppression, 54% (156 of 291) developed hyperpigmentation after a mean follow-up of 4.8 years (range, 0.3–13.2 years); 88% involved blue-gray pigmentation of normal skin that appeared most commonly in the lower (75%) and upper extremities (44%). The mean duration of minocycline therapy before hyperpigmentation was 1.5 years (range, 0.1–9 years) with a mean cumulative dosage of 107.3 g (range, 8.6–657 g). Notable risk factors include a history of vitamin D deficiency (relative risk [RR], 6.29; 95% confidence interval [CI], 1.91–15.27; P = .0052), presence of a shoulder prosthesis (RR, 3.2; 95% CI, 1.23–6.56; P = .0062), noncirrhotic liver pathology (RR, 3.63; 95% CI, 1.11–8.75; P = .0359), and use of a concurrent medication also known to cause hyperpigmentation (RR, 4.75; 95% CI, 1.83–10.1; P = .0029). Conclusions. Hyperpigmentation associated with the use of long-term minocycline suppression in patients with orthopedic infections is common.
Patients’ perceptions of a chronic pain rehabilitation program: changing the conversation
Craner, Julia R. , Skipper, Rosei R., Gilliam, Wesley P. , Sperry, Jeannie A., Morrison, Eleshia J, Morrison, Eleshia J. P.

Current Medical Research and Opinion | January 29, 2016 | Volume: 32 | Issue: 5 | Pages: 879-883

10.1185/03007995.2016.1149053 | PMID 26824738 Get It

An Autoimmune Basis for Diabetes-Related Chorea?
Ζεκερίδου, Αναστασία , Lennon, Vanda A.

Journal of Child Neurology | January 29, 2016 | Volume: 31 | Issue: 7 | Pages: 943-943

10.1177/0883073815627861 | PMID 26825928 Get It

Improved Diagnosis of Prosthetic Joint Infection by Culturing Periprosthetic Tissue Specimens in Blood Culture Bottles
Peel, Trisha , Dylla, Brenda L., Lynch, David T. , Greenwood‐Quaintance, Kerryl E. , Cheng, Allen , Mandrekar, Jayawant N. , Patel, Robin , Peel, Trisha N, Hughes, John G, Hughes, John , Patel, Robin

mBio | January 29, 2016 | Volume: 7 | Issue: 1 | Pages: No page available

10.1128/mbio.01776-15 | PMID 26733067 Get It

ABSTRACT Despite known low sensitivity, culture of periprosthetic tissue specimens on agars and in broths is routine. Culture of periprosthetic tissue samples in blood culture bottles (BCBs) is potentially more convenient, but it has been evaluated in a limited way and has not been widely adopted. The aim of this study was to compare the sensitivity and specificity of inoculation of periprosthetic tissue specimens into blood culture bottles with standard agar and thioglycolate broth culture, applying Bayesian latent class modeling (LCM) in addition to applying the Infectious Diseases Society of America (IDSA) criteria for prosthetic joint infection. This prospective cohort study was conducted over a 9-month period (August 2013 to April 2014) at the Mayo Clinic, Rochester, MN, and included all consecutive patients undergoing revision arthroplasty. Overall, 369 subjects were studied; 117 (32%) met IDSA criteria for prosthetic joint infection, and 82% had late chronic infection. Applying LCM, inoculation of tissues into BCBs was associated with a 47% improvement in sensitivity compared to the sensitivity of conventional agar and broth cultures (92.1 versus 62.6%, respectively); this magnitude of change was similar when IDSA criteria were applied (60.7 versus 44.4%, respectively; P = 0.003). The time to microorganism detection was shorter with BCBs than with standard media ( P < 0.0001), with aerobic and anaerobic BCBs yielding positive results within a median of 21 and 23 h, respectively. Results of our study demonstrate that the semiautomated method of periprosthetic tissue culture in blood culture bottles is more sensitive than and as specific as agar and thioglycolate broth cultures and yields results faster. IMPORTANCE Prosthetic joint infections are a devastating complication of arthroplasty surgery. Despite this, current microbiological techniques to detect and diagnose infections are imperfect. This study examined a new approach to diagnosing infections, through the inoculation of tissue samples from around the prosthetic joint into blood culture bottles. This study demonstrated that, compared to current laboratory practices, this new technique increased the detection of infection. These findings are important for patient care to allow timely and accurate diagnosis of infection.
PLEKHA7 defines an apical junctional complex with cytoskeletal associations and miRNA-mediated growth implications
Kourtidis, Antonis , Anastasiadis, Panos Z.

Cell Cycle | January 29, 2016 | Volume: 15 | Issue: 4 | Pages: 498-505

10.1080/15384101.2016.1141840 | PMID 26822694 Get It

Magnetic Resonance Imaging of Perirenal Pathology
Glockner, James F., Lee, Christine U.

Canadian Association of Radiologists Journal | January 29, 2016 | Volume: 67 | Issue: 2 | Pages: 149-157

10.1016/j.carj.2015.08.003 | PMID 26831730 Get It

The perirenal space can be involved by a variety of neoplastic, inflammatory, infectious, and proliferative disorders. Magnetic resonance imaging is often an ideal technique for identification and staging of lesions arising within the perirenal space, with its superior soft tissue characterization as well as its ability to visualize extension into blood vessels and adjacent organs. This pictorial essay describes the magnetic resonance imaging appearance of a variety of pathologies which can arise from or involve the perirenal space, and provides a framework for categorization and differential diagnosis of these lesions.
Diabetes-Associated Variation in TCF7L2 Is Not Associated With Hepatic or Extrahepatic Insulin Resistance
Varghese, Ron T. , Viegas, Iván , Barosa, Cristina , Marques, Catía , Rizza, Robert A., Jones, John G. , Shah, Mithun V , Vella, Adrian

Diabetes | January 29, 2016 | Volume: 65 | Issue: 4 | Pages: 887-892

10.2337/db15-1593 | PMID 26822092 Get It

A common genetic variation in TCF7L2 is associated with type 2 diabetes. However, the mechanism by which this occurs remains elusive. In addition to affecting insulin secretion, genetic variation at the TCF7L2 locus may alter insulin action or directly modify hepatic glucose metabolism. We sought to determine whether the diabetes-associated variant in this locus (the T allele of rs7903146) increases fasting endogenous glucose production (EGP), and impairs insulin-induced suppression of EGP and insulin-stimulated glucose disappearance. To address this, we studied individuals who were either homozygous for the diabetes-associated allele (TT) at rs7903146 or were homozygous for the protective allele (CC). Subjects were matched for other anthropometric characteristics and were studied using a euglycemic clamp. EGP and glucose uptake were measured using the tracer dilution technique, and the relative contribution of gluconeogenesis to EGP was quantitated using deuterated water corrected for transaldolase exchange. We report that the diabetes-associated variation in TCF7L2 did not associate with fasting EGP, insulin-induced suppression of EGP, and insulin-induced stimulation of glucose uptake. There was no association with the contribution of gluconeogenesis and glycogenolysis to EGP. These data indicate that genetic variation at TCF7L2 does not predispose an individual to type 2 diabetes by altering either hepatic or extrahepatic insulin action.